A prospective randomized trial was conducted in unselected, consecutive pateints with bleeding esophageal varices resulting from cirrhosis comparing (1) emergency portacaval shunt performed within 8 hr of initial contact (21 patients) with (2) emergency medical therapy (intravenous vasopressin and esophageal balloon tamonade) followed in 9 to 30 days by elective portacaval shunt in survivors (22 patients). All patients underwent the same diagnostic workup within 3 to 6 hr of initial contact, and received indentical supportive therapy initially. All patients were followed up for atleast 10 hr. The protocol contained no escape or crossover provisions. There were no statistically significant differences between the two treatment groups in the incidence of any of the clinical variables, results of laboratory tests or degree of portal hypertension. Child's risk classes in the shunt group were A-2 patients, B-8 patients and C-11 patients, whereas in the medical group they were A-10 patients, B-5 patients, and C-7 patients, a significant difference (p<0.01) that might have favored emergency medical treatment. Bleeding was controlled initially and permanently by emergency shunt in eve.ry patient, but by medical therapy in only 45% (p<0.001). Mean requirement for blood transfusion was 7.1+ 2.6 units in the shunt group and 21.4 + 2.6 units in the medical group (p<0.001). Eighty-one percent of the pateints in the shunt group were discharged alive compared with 45% in the medical group (p=0.027). Five-and 10-yr observed survival rates were 67% and 57%, respectively, after emergency shunt compared with 18% and 18%, respectively, after the combination of emergency medical therapy and elective shunt (p<0.01). These survival rates produced by emergency shunt performed within 8 hr of initial contact confirm the effectiveness of this procedure observed in our previous unrandomized studies. (Hepatology 1994; 20: 863-872 [3] Piai, G., Minieri, M., Catalano, M., D'Angelo, V., Sauro, A., Sabbatini, F. and Mazzacca, G. (1991). A prospective validation of two indexes of first variceal bleeding in liver cirrhosis (Abstract). Gastroenterology 100, A784.
A prospective randomized trial was conducted in unselected, consecutive pateints with bleeding esophageal varices resulting from cirrhosis comparing (1) emergency portacaval shunt performed within 8 hr of initial contact (21 patients) with (2) emergency medical therapy (intravenous vasopressin and esophageal balloon tamonade) followed in 9 to 30 days by elective portacaval shunt in survivors (22 patients) . All patients underwent the same diagnostic workup within 3 to 6 hr of initial contact, and received indentical supportive therapy initially. All patients were followed up for atleast 10 hr. The protocol contained no escape or crossover provisions. There were no statistically significant differences between the two treatment groups in the incidence of any of the clinical variables, results of laboratory tests or degree of portal hypertension. Child's risk classes in the shunt group were A-2 patients, B-8 patients and C-11 patients, whereas in the medical group they were A-10 patients, B-5 patients, and C-7 patients, a significant difference (p<0.01) that might have favored emergency medical treatment. Bleeding was controlled initially and permanently by emergency shunt in eve.ry patient, but by medical therapy in only 45% (p<0.001). Mean requirement for blood transfusion was 7.1+ 2.6 units in the shunt group and 21.4 + 2.6 units in the medical group (p<0.001). Eighty-one percent of the pateints in the shunt group were discharged alive compared with 45% in the medical group (p=0.027). Five-and 10-yr observed survival rates were 67% and 57%, respectively, after emergency shunt compared with 18% and 18%, respectively, after the combination of emergency medical therapy and elective shunt (p<0.01). These survival rates produced by emergency shunt performed within 8 hr of initial contact confirm the effectiveness of this procedure observed in our previous unrandomized studies. (Hepatology 1994; 20: [4, 5, 6] . Additionally, other effective non-operative therapies such as transjugular intrahepatic portosystemic shunt (TIPS) [7] and intravenous octreotide [4, 8] [2] [3] [4] . The assessment of these patients suggest [5] [7] . Clinical and biochemical data were recorded in each patient, and the severity of the liver disease was assessed using the Cambell numeral modification of Child's grading [13] .
The following portal hemodynamic parameters were evaluated in the 87 In conclusion, the study of Siringo et al. [5] shows, that a subgroup of cirrhotic patients is at a high risk of bleeding within 6 months of entry into the study. This The authors do recognise the potential effect of the pre-referral selection process in contributing to their good results. Further, it is noted that the authors have adopted the use of laparoscopy as a means of avoiding unnecessary laparotomy [3] . Our own experience suggests that a combination of laparoscopy and laparoscopic ultrasonography will avoid unnecessary nontherapeutic laparotomy [4] , the morbidity of which is not often appreciated from the publication of selected patients undergoing resectional surgery. The median survival of 18 [7, 8] . Prevention of initial variceal hemorrhage through shunt surgery is not beneficial. Prophylatic sclerotherapy of varices is also not an effective preventive strategy [8, 9] . Patients [10] . Well-known complications associated with endoscopic treatment include esophageal ulceration or perforation, cardiopulmonary sequelae, and infections, all of which may preclude transplantation or increase operative risk [10] [11] [12] . Additionally, vasoactive agents may be used for the aute treatment of bleeding varices [13] . Vasopressin with nitroglycerin, glypressin, somatostatin, and octreotide may effectively control variceal hemorrhage, but only glypressin has been shown to significantly improve survival. In the patient who has recovered from a variceal bleed, the addition of non-selective beta blockers to endoscopic therapy reduces rebleeding rates when compared to either therapy alone but mortality rates may not be significantly improved [14, 15] [16-181. TIPS controls acute variceal bleeding and prevents rebleeding in patients refractory to standard medical and endoscopic therapy. [19] [20] [21] [22] TIPS has been associated with a variety of complications [20] [21] [22] . Fifteen 
